Vitamin K Deficiency - Cleveland Clinic
Newborns often don’t get enough vitamin K at birth, which can cause vitamin K deficiency. It’s treatable, but it can be life-threatening.
my.clevelandclinic.orgHere are the latest publicly reported items on vitamin K deficiency as of 2026:
- Late-onset vitamin K deficiency bleeding (VKDB) remains a focus in neonates, with discussion highlighting that intramuscular vitamin K at birth is more effective than oral regimens for preventing VKDB, though some guidelines allow oral prophylaxis when IM is not accepted. This is based on recent case reviews and guideline summaries emphasizing the superior protection of IM vitamin K against late VKDB.[1][2]
- Global health guidelines continue to endorse giving vitamin K at birth to all newborns to prevent VKDB, with oral regimens proposed as secondary options when IM administration is refused; however, studies show oral regimens may be less reliable for late-onset VKDB, especially in breastfed infants.[2][1]
- News coverage in 2025–2026 notes isolated cases and policy debates related to vitamin K prophylaxis in newborns, including discussions of medical neglect cases where vitamin K prophylaxis was omitted, underscoring the ongoing importance of adherence to prophylaxis guidelines.[3]
- Recent clinical reviews consolidate current understanding of VKD (deficiency) across age groups, detailing the role of vitamin K in activating coagulation factors and the clinical implications of deficiency, with emphasis on prevention strategies in newborns and management of VKDB when it occurs.[6][9]
- Public-facing health resources continue to explain VKD and VKDB to caregivers, including the importance of vitamin K in blood clotting and the potential severity of bleeding disorders if prophylaxis is incomplete.[8][10]
Illustration: Neonatal VKDB prophylaxis typically follows this pathway:
- If parents consent to IM vitamin K at birth: single 1 mg IM dose to prevent VKDB.
- If IM is refused: a carefully structured oral vitamin K schedule (often multiple doses over weeks) is recommended as a secondary strategy, though evidence suggests higher risk of late VKDB with oral-only regimens.
If you’d like, I can pull the latest specific guidelines or major recent studies from a particular region (e.g., US, Europe, or Asia) and summarize their recommendations side by side. I can also create a brief patient-facing handout or a chart comparing IM versus oral prophylaxis effectiveness. Please tell me which format you prefer.
Citations:
- VKDB prevention guidance and the comparative effectiveness of IM vs oral regimens.[1][2]
- News coverage of VKD-related cases and policy discussions in 2025–2026.[3]
- Comprehensive reviews and guidelines on VKD across age groups.[9][6]
- Public education resources on VKD and VKDB.[10][8]